Kolexia
Bayreuther Giordana Caroline
Neurologie
Hôpital Pasteur
Nice, France
66 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Parkinson Tremblement Troubles de la motricité Hypocinésie Troubles neurologiques de la marche Ataxie Trouble du comportement en sommeil paradoxal Dystonie Nystagmus pathologique

Industries

Abbvie
10 collaboration(s)
Dernière en 2023
Merz
6 collaboration(s)
Dernière en 2023
Abbott
3 collaboration(s)
Dernière en 2021
Orion Pharma
3 collaboration(s)
Dernière en 2023

Dernières activités

ACTIVATE: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in Subjects With Parkinson's Disease With a Pathogenic Variant in the Glucocerebrosidase (GBA1) Gene
Essai Clinique (Bial R&D Investments, S.A.)   13 mars 2024
The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective study.
Journal of neurology   09 février 2024
A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society   30 janvier 2024
PERSO-PERF: Could Psycho-bio-social Context and Personality be a Predictive Factor of Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease Patients? - PERSO-PERF Study
Essai Clinique (CHU Toulouse)   30 janvier 2024
ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry   25 janvier 2024
Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson's disease.
Brain : a journal of neurology   03 octobre 2023
Reprogramming frequency in clinical practice: 6-months post-implantation of DBS for Parkinson’s disease subjects in ADROIT
Parkinsonism & related disorders   01 août 2023
F-FDopa positron emission tomography imaging in corticobasal syndrome.
Brain imaging and behavior   21 juillet 2023
Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson's disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial.
Journal of neurology   20 juin 2023
ADROIT: Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Essai Clinique (Abbott)   26 mai 2023